Results of a multicentre double-blind randomised placebo-controlled clinical trial evaluating the efficacy and safety of Mexidol in the treatment of Attention Deficit Hyperactivity Disorder in Children (MEGA)-Reference-Cited by-同舟云学术

Results of a multicentre double-blind randomised placebo-controlled clinical trial evaluating the efficacy and safety of Mexidol in the treatment of Attention Deficit Hyperactivity Disorder in Children (MEGA)

Published:2022 Issue:4 Volume:122 Page:75
ISSN:1997-7298
Container-title:Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova
language:en
Short-container-title:Z. nevrol. psikhiatr. im. S.S. Korsakova

Author:

Zavadenko N.N.^ORCID,Suvorinova N.Y.^ORCID,Batysheva T.T.^ORCID,Bykova O.V.^ORCID,Platonova A.N.^ORCID,Gaynetdinova D.D.^ORCID,Levitina E.V.^ORCID,Mashin V.V.^ORCID,Vakula I.N.^ORCID,Maximova N.E.^ORCID

Publisher

Media Sphere Publishing Group

Subject

Psychiatry and Mental health,Neurology (clinical)

Reference33 articles.

1. Diagnostic and Statistical Manual of Mental Disorders

2. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

3. ICD-11 International Classification of Diseases 11th Revision The global standard for diagnostic health information. https://icd.who.int/ru

4. Federal State Budgetary Institution «Federal Medical Research Center for Psychiatry and Narcology named after V.P. Serbsky» of the Ministry of Health of Russia. Hyperkinetic Disorders (ADHD). Koren E, Kupriyanova T. eds. 2015. (In Russ.)

5. Zavadenko NN. Hyperactivity and deficiency of attention at children’s age. M.: Jurite; 2019. (In Russ.)

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mexidol, Cytoflavin, and succinic acid derivatives as antihypoxic, anti‐ischemic metabolic modulators, and ergogenic aids in athletes and consideration of their potential as performance enhancing drugs;Drug Testing and Analysis;2024-02-25

2. Unauthorized ingredients in “nootropic” dietary supplements: A review of the history, pharmacology, prevalence, international regulations, and potential as doping agents;Drug Testing and Analysis;2023-06-25

3. Neurodevelopmental Disorders in Children: Neuroplasticity and the Possibilities of Nootropic Pharmacotherapy;Neurochemical Journal;2023-06

4. Neurodevelopmental Disorders in Children: Neuroplasticity and Possibilities of Nootropic Pharmacotherapy;Нейрохимия;2023-04-01

5. The possibilities of Mexidol usage in neuropediatrics;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2023